Monash IVF Group Ltd (AU:MVF)
ASX:MVF
Want to see AU:MVF full AI Analyst Report?
MVF Stock Chart & Stats
AU$0.76
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.76
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.54 - AU$0.90
Previous CloseN/A
Volume300.99K
Average Volume (3M)2.18M
Market Cap
AU$272.74M
Enterprise ValueAU$558.45M
Total Cash (Recent Filing)AU$8.14M
Total Debt (Recent Filing)AU$281.81M
Price to Earnings (P/E)17.9
Beta1.19
Next Earnings
Aug 24, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield6.22%
Share Statistics
EPS (TTM)0.04
Shares Outstanding389,634,830
10 Day Avg. Volume1,374,502
30 Day Avg. Volume2,181,726
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.12
Price to Sales (P/S)1.01
P/FCF Ratio588.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.86Price Target Upside12.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$267.01M
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Healthy Profit MarginsA large reported revenue uplift and stable gross and net margins indicate durable demand for fertility services and scalable clinic/lab economics. Sustained top-line expansion plus double-digit gross margins support reinvestment in capacity, clinical capabilities and long-term profitability.
Moderate Leverage With Positive ROEA balanced debt-to-equity ratio near 0.7 combined with a 10.2% ROE suggests the group uses leverage to amplify returns without extreme financial risk. This capital structure supports funding clinic expansion and capex while leaving room to manage obligations over the medium term.
Positive Operating Cash Flow From Core OperationsConsistent positive operating cash flow indicates the underlying fertility services generate real cash, supporting day-to-day operations and patient-service delivery. Over months this operational cash underpinning is crucial for funding working capital and sustaining clinic operations despite FCF volatility.
Bears Say
Severe Free Cash Flow DeclineA near-total collapse in free cash flow materially reduces internal funding for capex, dividends and debt reduction. Sustained low FCF over several quarters would force reliance on external capital, constrain strategic investments and increase refinancing or liquidity risk for the business.
Weak Conversion Of Earnings To CashA low OCF-to-net-income ratio implies reported profits are not converting into cash efficiently, pointing to receivables, accruals or non-cash accounting benefits. Over months this weak conversion can undermine balance sheet resilience and limit the company’s ability to self-fund growth or absorb shocks.
Increased Debt Levels Raise Leverage RiskRising debt, even if currently moderate, increases fixed obligations and sensitivity to interest costs. Coupled with sharply reduced free cash flow, higher leverage narrows financial flexibility, elevates refinancing risk and could pressure margins if operating conditions moderate.
Monash IVF Group Ltd News
MVF FAQ
What was Monash IVF Group Ltd’s price range in the past 12 months?
Monash IVF Group Ltd lowest share price was AU$0.54 and its highest was AU$0.90 in the past 12 months.
What is Monash IVF Group Ltd’s market cap?
Monash IVF Group Ltd’s market cap is AU$272.74M.
When is Monash IVF Group Ltd’s upcoming earnings report date?
Monash IVF Group Ltd’s upcoming earnings report date is Aug 24, 2026 which is in 75 days.
How were Monash IVF Group Ltd’s earnings last quarter?
Monash IVF Group Ltd released its earnings results on Feb 25, 2026. The company reported AU$0.018 earnings per share for the quarter, missing the consensus estimate of AU$0.025 by -AU$0.007.
Is Monash IVF Group Ltd overvalued?
According to Wall Street analysts Monash IVF Group Ltd’s price is currently Undervalued.
Does Monash IVF Group Ltd pay dividends?
Monash IVF Group Ltd pays a Semiannually dividend of AU$0.012 which represents an annual dividend yield of 6.22%. See more information on Monash IVF Group Ltd dividends here
What is Monash IVF Group Ltd’s EPS estimate?
Monash IVF Group Ltd’s EPS estimate is 0.03.
How many shares outstanding does Monash IVF Group Ltd have?
Monash IVF Group Ltd has 389,634,830 shares outstanding.
What happened to Monash IVF Group Ltd’s price movement after its last earnings report?
Monash IVF Group Ltd reported an EPS of AU$0.018 in its last earnings report, missing expectations of AU$0.025. Following the earnings report the stock price went up 2.954%.
Which hedge fund is a major shareholder of Monash IVF Group Ltd?
Currently, no hedge funds are holding shares in AU:MVF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Monash IVF Group Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.86 (12.63% Upside)
AU$0.86 (12.63% Upside)
Blogger Sentiment
Bullish
AU:MVF Sentiment 94%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.39%
12-Months-Change
Fundamentals
Return on Equity
6.06%
Trailing 12-Months
Asset Growth
0.49%
Trailing 12-Months
Company Description
Monash IVF Group Ltd
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
MVF Stock 12 Month Forecast
Average Price Target
AU$0.86
▲(12.63% Upside)
Technical Analysis
Healius Limited
―
Sonic Healthcare Limited
―
Integral Diagnostics Ltd.
―
Australian Clinical Labs Ltd
―
Options Prices
Currently, No data available
---